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Abstract 
Ebola virus is a highly contagious haemorrhagic fever which has lead to the recent destruction in parts of Africa 
where  nearly half of the population of Africa has been eroded. While measures were taken to halt the transmission 
if the disease, the modes of transmission of the virus were detected. Fomites were seen as the physical modes of 
transmission from the infected wards of the ebola patients while the bodily fluids in the fomites are responsible for 
the healthy human to be infected. The fluids such as tears, blood and urine are secreted from the organs such as eyes, 
heart and kidney where they are filled within those organs which leads to the damage of the entire organs. Other 
fluids such as the nasal blood, breast milk and sweat are from nose, gonads and skin while saliva, semen, vomit, 
sputum, stool are also responsible for the transmission of the ebola virus. The fomites such as the doctor’s blood 
stained gloves and the bloody intravenous insertion site carry the ebola virus through the bodily fluids. This helps in 
preventing the wide spread of the fatal haemorrhagic fever, ebola.   
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1. INTRODUCTION 
Why is the current population in Africa is only half of the population that was found before the year 2014? Why 
people from Africa have been quarantined and are unable to travel to other places like any other country people? It was 
a great shock to the people of Africa when they had to lose their people because of the fatal haemorrhagic fever, ebola. 
It was necessary to save these people from the deadly disease which was very contagious. Thus the idea arose to find 
out the modes of transmission of the virus. This must be accessed only through the ebola infected people and their 
surroundings. It was found that through the bodily fluids of the ebola infected person the disease spread to other healthy 
people. Research was also conducted where the ebola patients were treated and thus few fomites also were found to be 
behind the infection of the contagious haemorrhagic fever. All these data required large space to be stored and analysed 
which also may be processed and retrieved later to find a solution to this problem which led to the arousal of bigdata in 
this case. Making predictions about the disease based on the real-time data gathered from the hospitals will change the 
current scenario in the case of ebola [8]. Improvising the speed of data analysis by having the factors that lead to the 
widespread of the disease helps to save the people who are suffereing from the diasease and later also people who will 
be attacked by the disease.  For such large amount of data,data mining cannot provide solution. As the days go by, the 
fatality rate of the people affected by ebola is on the increase. Thus we find solution to prevent the disease rather than 
being affected and then suffer with the disease. 
The most popular ways in which ebola are affected are from the endothelial cells [9], semen [11], and blood products 
[14]. It is easy to analyse the infection but difficult to prevent the wide spread of these disease from the sources. This 
paper explains the physical modes of transmission of the disease from one person to another by which they can help in 
preventing the disease from affecting the people. 
 
Modes of transmission of the Ebola Virus: The fluids and fomites that have been found to transmit the disease is 
found to affect the organs such as the eyes, heart, kidney, lung and the liver. Later components such as the doctor’s 
blood stained gloves and the bloody intravenous insertion site are the physical modes of transportation of the virus. 
2.  Requirements 
2.1  Fluids 
The contagious diseases are generally either airborne or waterborne. When ebola virus is been considered, it is 
proved that it is transmitted through the bodily fluids such as saliva, stool, semen, breast milk, urine, vomit, sputum, 
tears, nasal blood, and a skin swab(sweat).Through the given fluids the caregivers and the family members can be 
affected. To prevent this the caregivers are given coats, helmets, aprons, gloves and shoes so that the virus in these body 
fluids cannot affect them. All the visitors of the patient might also be given some precautionary equipment to guard 
themselves from the fatal disease. Blood has all the contents of the virus which is the direct way of transmission and 
therefore before blood donation, it should be carefully tested for infections such as ebola. 
 
Table 1. Virus culture and results from 54 clinical samples collected from 26 patients with laboratory-confirmed  Ebola hemorrhagic fever. 
Sample type, 
Phase of illness 
Patients 
No. 
Samples 
No. 
Day after disease onset 
that sample was collected, 
range (mean) 
Virus culture 
positive, no. (% 
sample type tested) 
No./total 
tested (%) 
Latest day 
positive after 
disease onset 
Saliva       
Acute  10 12 4 – 14 (6) 1 (8) 8/12 (67) 8 
Convalescent 4 4 12 – 23 (16) 0 (0) 0/4 (0) - 
Skin       
Acute  7 8 4 – 10 (7) 0 (0) 1/8 (13) 6 
Convalescent 3 3 7 – 15 (12) 0 (0) 0/3 (0) - 
Urine       
Acute  6 7 5 – 22 (14) 0 (0) 0/7 (0) - 
Convalescent 4 4 8 – 40 (28) 0 (0) 0/4 - 
Vomit       
Acute  1 1 NA (9) 0 (0) 0/1 (0) - 
Convalescent 1 1 NA (20) 0 (0) 0/1 (0) - 
Sputum       
Acute  1 1 NA (8) 0 (0) 0/1 (0) - 
58   C. Jemimah and S. Lilly Sheeba  /  Procedia Computer Science  92 ( 2016 )  56 – 62 
Convalescent 1 1 NA (16) 0 (0) 0/1 (0) - 
Breast milk       
Acute  1 1 NA (7) 1 (100) 1/1 (100) 7 
Convalescent 1 1 NA (15) 1 (100) 1/1 (100) 15 
Stool, acute 4 4 4 – 12 (8) 0 (0) 2/4 (50) 12 
Sweat, acute 1 1 NA (9) 0 (0) 0/1 (0) - 
Tears, acute 1 1 NA (6) 0 (0) 1/1 (100) 6 
Nasal blood, acute 1 1 NA (10) 0 (0) 1/1 (100) 10 
Body louse, acute 1 1 NA (9) 0 (0) 0/1 (0) - 
Semen, convalescent 1 1 40 – 45 (43) 1 (50) 1/2 (50) 40 
Subtotal acute 23 38 4 – 22 (9) 2 (5) 14 (37) 12 
Subtotal Convalescent 8 16 7 – 45 (21) 2 (13) 2 (13) 40 
Total 26 54 4 – 45 (12) 4 (7) 16 (30) - 
   
 
2.2  Fomites 
 
Every contagious disease may also have a physical mode of transmission where the fomites that are associated with 
the transmission of the ebola virus are the the wall, desk, light switch, floor, aprons, gloves, sthethoscope, bed, bowl, 
corpse, body bag, mattress, intravenous tubing, intravenous insertion site which have direct contact with the patient. 
Thereby they carry the infection to the caregivers and the family members. Thus all the fomites that may transmit the 
virus through the body fluids must be disposed safely. The corpse must be cremated promptly so that the spread of the 
disease does not get aggressive. 
 
Table 1. Virus culture and results from 33 environmental samples. 
Sample Color Virus culture result Result 
Outside of ward Clear - - 
Changing room wall Clear - - 
Changing room desk Clear - - 
Exterior surface of door of isolation ward    
Inside ward, suspected side Clear - - 
Nurse’s newly placed glove Clear - - 
Bed frame Clear - - 
Instrument tray for ward rounds    
Inside ward, probable side Clear - - 
Air (tube opened and capped, negative control 1) Clear - - 
Sterile swab (negative control 2) Clear - - 
Intravenous fluid support pole Clear - - 
Light switch Clear - - 
Floor Clear - - 
Handle of 0.05% bleach solution dispenser Clear - - 
Nurse’s clean apron Clear - - 
Nurse’s clean glove Clear - - 
Clean stethoscope Clear - - 
Stethoscope after use Clear - - 
Stethoscope after use and rinsing with 0.05% bleach solution Clear - - 
Bed frame Clear - - 
Bedside chair (2 different samples) Clear - - 
Food bowl Clear - - 
Spit bowl Clear - - 
Skin (hand) of patient attendants (3 different samples) Clear - - 
Clean glove of patient attendant Clear - - 
Corpse decontaminated with 0.5% bleach solution Clear - - 
Body bag decontaminated with 0.5% bleach solution (2 different samples) Clear - - 
Clean mattress Clear - - 
Intravenous tubing Clear - - 
Doctor’s blood stained glove (positive control 1) Pink - + 
Bloody intravenous insertion site (positive control 2) Red - + 
Total (% of all samples) - 0 (0) 2 (7) 
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2.3 Organs 
 
All the bodily fluids are secreted from the organs which flows and circulates to all the parts of the body thereby 
infecting the body which leads to the repair of all the body parts. It starts with defunctioning where each body part dies 
one by one resulting in the death of the particular body. During the intial stage of this process internal bleeding takes 
place and the later stage will end up in external bleeding. This results in bleeding while vomiting, along with the 
sputum, along with urine, along with stool, along with cough and also it bleeds through the ears, nose, gums and vagina. 
 
Fig. 1. (a) lymph nodes and spleen; (b)Gastro-intestine; (c)Adrenal glands and kidneys. 
2.4  Transmission 
 
A natural tendency of human is to urinate periodically whereby the caregivers assist the patients and when the urine 
splashes on the caregivers then they may be affected by ebola. Through the semen that is transferred during the sexual 
intercourse also transmits ebola virus. From the mothers who breastfeed their infants, the infants are been affected by 
ebola through the breast milk. Apart from all these it may also be transmitted from the hospitals by the infected fomites 
such as the instruments used by the doctors that helps to treat the patients such as the gloves, intravenous tubes and 
stethoscope. 
 
2.5  Fatality 
 
When fatality is been considered in the case of ebola the death cases are almost equal with the infected cases. Three 
regions in Africa namely, Liberia, Guinea and Sierra leone are affected which has led to the decrease in the population 
of Africa. Not only Africa has been affected but also other countries have been affected due to the people of Africa who 
have travelled to other countries. Thus the other countries have also lost its people due to tha fatal haemorrhagic fever. 
Measures were taken to quarantine the people who come from Africa. Later, people of Africa were halted for a few days 
from travelling to other countries so that the spread of the contagious disease would not get aggressive. 
 
3.  Use of Bigdata in Analysis of Ebola  
 
Analysis of ebola requires a lot of patient data to be stored which requires petabytes of data as the number of patients 
who have been affected by ebola is on the increase day by day. Tools such as Hadoop, YARN, Oozie, Hive, Pig, 
MongoDB, Cassandra, Flume, Spark, Storm, Sqoop are used where each has its own method of providing solutions. 
This analysis will help to find treatment for the ebola patients which has not been found as yet. Further for the 
prevention also, measures such as vaccination can be found for which these analysis may prove to be useful.  
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Algorithm 1: Mapreduce 
 
Input: 
Patient data 
Output: 
Mapper – analysis of the patient data 
Reducer – aggregation of the analysis a s a result 
 
Algorithm 2: IMDB Ebola Rating 
 
Input: 
R = average of ebola patient factors (mean) = (Rating) 
v = number of value for the ebola patient factors = (value) 
m = minimum value required to be listed in fatality  
C = the mean value across the whole report  
Output: 
ER = value/(value+min value) × average rating + min value/(value+min value) × total mean value 
 
4.  Interaction with the immune genes 
 
Every human has an immune gene which is responsible for resisting the foreign particle that has entered the body. 
The reason why death in the case of ebola is much fast after its attack is the replication of the virus within the body. 
This can be prevented only if the patient has a immunity and resistive power in their body which does not allow the 
replication of the ebola virus within the body. Human Leukocyte Antigen-B is found to play a major role where its 
alleles are said to be resistive in nature which is the immune gene that is present in every human. In case of the fatality 
rate also, people who have strong immune gene alleles are found to survive ebola since it halts the replication of the 
virus thus preventing it from getting aggressive  
 
5.  Frozen Plasma Infusion and Rehydration treatment 
 
Correction of coagulopathy is done in order to provide nutrition support where platelets should be transfused if less 
than 50,000. Fresh frozen plasma must be infused in case of serious bleeding. This can be stored for many days which 
can also be transported from one place to another. Through the enzymatic cleavage of the mRNA type of double 
stranded RNAs silence their target genes. In the outbreak that happened in the year 1995 at kikwit, 9 patients received 
convalescent whole blood transfusions and 7 recipents survived out of 12.5 % of case fatality rate. These can be 
collected either from people who have survived ebola or from people who have strong immune gene. Apart from this, 
Oral Rehydration Salt can be given to the patients along with water in order to provide them with the minerals which 
have been drained out. Regular intake of nutritious food helps get better since there is continuous bleeding which loses 
out their total energy.  
 
6.  Conclusions and perspectives 
 
Bigdata and predictive analytics is expected to make a difference in the fatality rate of ebola  by providing ways in 
order to prevent the transmission of the infection from one person to another by determining the modes of transmission 
of ebola. It also provides solution to decrease the fatality rate even after the infection of ebola. Considering the volume 
and heterogenous nature of future data, a well-defined mechanism is needed to reduce the time involved in the analysis 
which improves the performance of data analysis. It is a fact that issues such as data generation, security, visualization, 
processing exist. But still we have large storage space and high computational speed. To make full use of all the 
available data, data from various platforms are collected which cannot be used as it is where integrative analytics can be 
used which provides a comprehensive understanding of the function with well-equipped tools with low costs. Thus the 
gathered information can be used for further analysis of the disease. Though there are technical defects, the 
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computational predictions are accurate and efficient which can be further taken into mathematical and statistical  
analysis methods. 
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